Immune Thrombocytopenia Clinical Trials

232 clinical trials for Immune Thrombocytopenia across international registries, including 56 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP) — RECRUITING · PHASE2
• A multi-center, open-label, single-arm study to evaluate the efficacy and safety of oral rilzabrutinib in adults with immune thrombocytopenia (ITP) who failed first-line treatment — RECRUITING · PHASE3
• Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders — RECRUITING · PHASE2
• A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag — RECRUITING
• Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) — RECRUITING · PHASE1
• Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) — RECRUITING · PHASE1
• A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia — RECRUITING · PHASE1
• Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment — RECRUITING · PHASE3
• Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia — RECRUITING · PHASE2
• Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia — RECRUITING · PHASE2
• Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis — RECRUITING · NA
• Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia — RECRUITING · PHASE1
• Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia — RECRUITING · PHASE1
• A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP) — RECRUITING · PHASE1
• Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) — RECRUITING · PHASE2
• Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) — RECRUITING · PHASE2
• Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) — RECRUITING · PHASE2
• Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP) — RECRUITING · PHASE2
• A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11) — RECRUITING · PHASE2
• V-IMMUNE® for Immune Thrombocytopenia — RECRUITING · PHASE3
• French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia — RECRUITING
• A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia — RECRUITING · PHASE1
• A Phase 1/2, Dose-finding Study Investigating the Safety and Efficacy of Pirtobrutinib in Adults with Immune Thrombocytopenia — RECRUITING · PHASE2
• Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP) — RECRUITING · PHASE2
• Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP) — RECRUITING · PHASE1
• An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases — RECRUITING · PHASE1
• The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2) — RECRUITING · PHASE2
• Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia — RECRUITING · NA
• Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP) — RECRUITING · PHASE2
• A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia — RECRUITING · PHASE1
• ITP Registry and Accompanying Biospecimen Collection — RECRUITING
• Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP) — RECRUITING · PHASE2
• A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia — RECRUITING · PHASE1
• A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus — RECRUITING · PHASE1
• Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia — RECRUITING
• An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia — RECRUITING · PHASE2
• Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies — RECRUITING · PHASE2
• A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP) — RECRUITING · PHASE2
• A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia — RECRUITING · PHASE2
• Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia — RECRUITING · PHASE2
• A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia — RECRUITING · PHASE2
• Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia — RECRUITING
• Longitudinal Cohort of Thrombosis and Hemostasis Diseases — RECRUITING
• Role of Acute Phase Proteins In Diagnosis of Immune Thrombocytopenia — RECRUITING · NA
• Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia — RECRUITING
• Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy — RECRUITING · PHASE2
• Observatory of Immunological Thrombopenic Purpura in the Brest Region — RECRUITING
• TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination — RECRUITING · PHASE2
• Biologic Characterization of Patients With ITP — RECRUITING · NA
• Short-course High-dose Prednisone and Dexamethasone in Children With ITP — RECRUITING · PHASE4

Refine this search